Is a complete GRI research report available?

No complete published report is available for GRI Bio, Inc. (GRI) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

GRI Bio, Inc. (GRI)

NASDAQ: GRI · USD

$1.45

-0.05 (-3.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first GRI analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	2.6M
Net income (ttm)	-10.9M
EPS (ttm)	-$27.0
Shares out	1.8M
Volume	29,763
Beta	-0.67
Price target	$21.0	+1348.3%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -10.9M
EPS (ttm): -$27.0
Market cap: 2.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All GRI indicators

Market & fundamental data

Available fields

172

Groups with data

Currency

USD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001824293
Company name	GRI Bio, Inc.
Country	United States
Country code	US
Cusip	3622AW502
Employees	4
Employees Change	3%
Employees Change Percent	300
Enterprise value	$-8.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US3622AW5029
Last refreshed	2026-07-27
Market cap	$2.6M
Market cap category	Nano-Cap
Price	$1.45
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	GRI
Website	https://www.gribio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-424.81%
FCF yield	-472.72%
P/B ratio	0.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-10.9M
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Profit Per Employee	$-2.7M
ROA	-88.82
Roa5y	-266.3
ROCE	-103.6
ROE	-185.7
ROIC	-114.6

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-97.47%
Cagr3y	-97.9%
EPS Growth Quarters	1
EPS Growth Years	4
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$11.3M
Cash	$11M
Current Assets	$11.3M
Current Liabilities	$794,000
Debt	$58,000
Debt Equity	$0.01
Equity	$10.5M
Liabilities	$794,000
Long Term Assets	$60,000
Long Term Liabilities	$0
Net Cash	$11M
Net Cash By Market Cap	$428
Net Cash Growth	246.36%
Net Debt Equity	$-1.04
Tangible Book Value	$10.5M
Tangible Book Value Per Share	$6.65
WACC	0.53

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	14.21
Net Working Capital	$-505,000
Quick ratio	13.91
Working Capital	$10.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3,546.32%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-97.46%
200-day SMA	14.66
3Y total return	-100%
50-day SMA	1.93
50-day SMA vs 200-day SMA	50under200
All Time High	577,401.2
All Time High Change	-100%
All Time High Date	2023-04-24
All Time Low	1.41
All Time Low Change	2.84%
All Time Low Date	2026-07-24
ATR	0.12
Beta	-0.67
Beta1y	1.46
Beta2y	2.46
Ch YTD	-79.02
High	1.52
High52	80.36
High52 Date	2025-09-11
High52ch	-98.2%
Low	1.41
Low52	1.41
Low52 Date	2026-07-24
Low52ch	2.84%
Ma50ch	-24.87%
Price vs 200-day SMA	-90.11%
RSI	31.68
RSI Monthly	3.87
RSI Weekly	22.04
Sharpe ratio	-2.21x
Sortino ratio	-2.52
Tr YTD	-79.02
Tr1m	-22.04%
Tr1w	-3.33%
Tr3m	-39.83%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-1.2
Operating Income	$-10.9M
Price target	$21
Price Target Change	$1,348

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,770,836%
Float Percent	100%
Shares Insiders	0%
Shares Institutions	2.8%
Shares Out	1,770,838
Shares Qo Q	518.4%
Shares Yo Y	3,546.32%
Short Float	6.49%
Short Ratio	0.96
Short Shares	6.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.7M
Average Volume	40,412.55x
Bv Per Share	6.65
CAPEX	$-3,000
Ch1m	-22.04
Ch1w	-3.33
Ch1y	-97.46
Ch3m	-39.83
Ch3y	-100
Ch6m	-74.27
Change	-3.33%
Change From Open	-4.61
Close	1.5
Days Gap	1.33
Depreciation Amortization	4,000
Dollar Volume	43,156.4
Earnings Date	2026-08-13
Earnings Time	bmo
EBIT	$-10.9M
EBITDA	$-10.9M
EPS	$-27.02
F Score	1
FCF	$-12.1M
FCF EV Yield	144.12x
FCF Per Share	$-6.85
Financing CF	19,905,000
Fiscal Year End	December
Founded	2,018
Investing CF	-3,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Last Split Date	2026-01-26
Last Split Type	Reverse
Last10k Filing Date	2026-01-30
Ma150	3.21
Ma150ch	-54.8%
Ma20	1.66
Ma20ch	-12.86%
Net CF	7,767,000
Next Earnings Date	2026-08-13
Open	1.52
Optionable	No
Position In Range	36.36
Post Close	1.45
Postmarket Change Percent	1.38
Postmarket Price	$1.47
Ppne	60,000
Price Date	2026-07-24
Ptbv Ratio	0.24
Relative Volume	0.74x
Share Based Comp	604,000
Tr6m	-74.27%
Us State	California
Volume	29,763

GRI Bio, Inc. (GRI)

Coverage state: Market snapshot only — no published research

Generate the first GRI analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · GRI

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GRI indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on GRI

Frequently asked questions